Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6. This reflects a routine version update and does not alter the study details or other visible content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays a standard error screen indicating the content is temporarily unavailable. The previously visible study record details are no longer shown.SummaryDifference17%

- Check38 days agoChange DetectedThe study page now indicates the trial is no longer recruiting participants. The update notes that the last known status was set by Academic and Community Cancer Research United on 2024-07 and that the last verification status is Unknown.SummaryDifference0.4%

- Check45 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page template; the study details shown remain the same.SummaryDifference0.1%

- Check67 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3, indicating a minor page update without altering the study content.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the study details page has been published.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.